Short answer

Designers should consider the synergistic effects of multiple excipients in formulation development to create advanced drug delivery systems that optimize drug performance and patient outcomes.

Field
Commercial Production
Source
AAPS PharmSciTech (2026)
Method
Experimental design (D-optimal), In-vitro studies, microbiological assays, In-vivo studies, ex-vivo permeation studies, microscopy.
Evidence
Strong effect

A carefully optimized nanovesicular formulation significantly improves the delivery and antifungal potency of a drug, demonstrating a substantial enhancement in efficacy and tissue penetration. This commercial production research insight is drawn from a 2026 study published in AAPS PharmSciTech. Using Experimental design (d-optimal), in-vitro studies, microbiological assays, in-vivo studies, ex-vivo permeation studies, microscopy., researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers should consider the synergistic effects of multiple excipients in formulation development to create advanced drug delivery systems that optimize drug performance and patient outcomes.

Study
Commercial ProductionNew This WeekStrong effect

Optimized Nanovesicular System Enhances Antifungal Drug Delivery and Efficacy by 2.18x

A carefully optimized nanovesicular formulation significantly improves the delivery and antifungal potency of a drug, demonstrating a substantial enhancement in efficacy and tissue penetration.

AAPS PharmSciTech · 2026

01

Key Findings

  • 01Optimized nanovesicular system (TSB) achieved high entrapment efficiency (91.6%), small vesicle size (217.9nm), and stable zeta potential (-24.1mV).
  • 02TSB demonstrated superior antifungal performance compared to the drug suspension, with a larger inhibition zone, lower MIC and MFC, and a 33% faster fungicidal effect.
  • 03Ex-vivo studies showed a 2.18-fold enhancement ratio in drug permeation, with confocal microscopy confirming deeper tissue penetration.
  • 04Histopathological analysis confirmed the safety of the topical formulation without causing tissue damage.
02

Application

Design takeaway

Designers should consider the synergistic effects of multiple excipients in formulation development to create advanced drug delivery systems that optimize drug performance and patient outcomes.

How to apply

When developing topical formulations, systematically investigate the impact of excipient ratios on particle size, stability, drug release, and ultimately, therapeutic efficacy and penetration.

Project actions

  • 01When designing a product that delivers an active ingredient, think about how the carrier system (like a cream, gel, or nanoparticle) can be optimized to improve performance.
  • 02Consider using experimental design techniques to efficiently explore the effects of multiple formulation variables.
03

Method & Evidence

AimTo develop and optimize a novel tetra-synergistic bilosome formulation for enhanced delivery and efficacy of an antifungal agent in treating otomycosis.
MethodExperimental design (D-optimal), In-vitro studies, microbiological assays, In-vivo studies, ex-vivo permeation studies, microscopy.
ProcedureResearchers utilized a D-optimal design to systematically vary three formulation factors (Cremophor® EL: VOR ratio, sodium deoxycholate: cholesterol ratio, and Brij® 58: Brij® S2 ratio) to optimize entrapment efficiency, vesicle size, and zeta potential. The optimized formulation was characterized using FTIR and TEM, and its drug release profile, stability, antifungal activity (inhibition zone, MIC, MFC), ex-vivo permeation, and tissue penetration were evaluated. Safety was assessed through histopathological analysis.
ContextPharmaceutical formulation and drug delivery for topical antifungal treatment.

Variables

IV["Ratios of Cremophor® EL: VOR","Ratios of sodium deoxycholate: cholesterol","Ratios of Brij® 58: Brij® S2"]
DV["Entrapment efficiency (%)","Vesicular size (nm)","Zeta potential (mV)","In-vitro release profile","Antifungal activity (inhibition zone, MIC, MFC)","Ex-vivo permeation enhancement ratio","Tissue penetration depth"]
CV["Type of active ingredient (Voriconazole)","Target pathogen (Candida albicans)","Type of nanovesicle (bilosomes)","Ex-vivo tissue model","Storage conditions for stability testing"]
04

Strengths & Limitations

Strengths

  • +Comprehensive evaluation using multiple study types (in-vitro, microbiological, in-vivo, ex-vivo).
  • +Systematic optimization using experimental design (D-optimal).
  • +Clear demonstration of enhanced efficacy and safety.

Limitations

The complexity of the nanovesicle formulation and the specialized equipment required for characterization and testing can be a barrier for simpler design projects.

Reliability & validity

The use of a D-optimal design and multiple characterization techniques enhances the validity of the findings. Reliability would be supported by repeating key experiments and ensuring consistent results across batches.

Think critically

How might the principles of optimizing nanovesicular systems be applied to non-pharmaceutical products, such as delivering pigments in paints or nutrients in fertilizers?

05

Design Principles

"Precise control over formulation variables can unlock enhanced therapeutic potential and delivery characteristics of active pharmaceutical ingredients."

This research highlights the critical role of formulation design in overcoming drug delivery challenges. By precisely controlling the ratios of key excipients, designers can create advanced delivery systems that not only protect the active ingredient but also actively enhance its therapeutic performance and safety profile.

06

What This Means for Your Design

By carefully mixing different ingredients in a specific way, scientists created tiny bubbles that carried an antifungal medicine much better than the plain medicine, making it work faster and go deeper into the skin to fight the infection.

How to use in your project

  • 1.Reference this study when discussing the optimization of delivery systems for active ingredients, particularly in the context of improving efficacy or overcoming formulation challenges.
07

Add to My Project

08

Quick Cite

Paragraph starter

The optimization of nanovesicular systems, as demonstrated by Fahmy et al. (2026), provides a compelling example of how precise formulation control can significantly enhance drug delivery and therapeutic outcomes. Their work on tetra-synergistic bilosomes for otomycosis management achieved a 2.18-fold increase in drug permeation and superior antifungal efficacy, underscoring the potential of advanced delivery platforms to overcome biological barriers and improve treatment effectiveness.

09

Source

AAPS PharmSciTech

Harnessing Novel Tetra-Synergistic Bilosomes for Effective Otomycosis Management: Integrated In-Vitro, Microbiological and In-vivo Studies

journal · 2026

View source

Questions About This Research

What does the research say about optimized nanovesicular system enhances antifungal drug delivery and efficacy by 2.18x?
Designers should consider the synergistic effects of multiple excipients in formulation development to create advanced drug delivery systems that optimize drug performance and patient outcomes. Evidence: AAPS PharmSciTech (2026).
Why does "Optimized Nanovesicular System Enhances Antifungal Drug Delivery and Efficacy by 2.18x" matter for design?
This research highlights the critical role of formulation design in overcoming drug delivery challenges. By precisely controlling the ratios of key excipients, designers can create advanced delivery systems that not only protect the active ingredient but also actively enhance its therapeutic performance and safety profile.
How can designers apply this research?
Designers should consider the synergistic effects of multiple excipients in formulation development to create advanced drug delivery systems that optimize drug performance and patient outcomes.
What were the main findings?
Optimized nanovesicular system (TSB) achieved high entrapment efficiency (91.6%), small vesicle size (217.9nm), and stable zeta potential (-24.1mV).. TSB demonstrated superior antifungal performance compared to the drug suspension, with a larger inhibition zone, lower MIC and MFC, and a 33% faster fungicidal effect.. Ex-vivo studies showed a 2.18-fold enhancement ratio in drug permeation, with confocal microscopy confirming deeper tissue penetration.. Histopathological analysis confirmed the safety of the topical formulation without causing tissue damage.
What research method was used?
Experimental design (D-optimal), In-vitro studies, microbiological assays, In-vivo studies, ex-vivo permeation studies, microscopy..
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2026 journal from AAPS PharmSciTech.
What should I do differently in my next project?
When developing topical formulations, systematically investigate the impact of excipient ratios on particle size, stability, drug release, and ultimately, therapeutic efficacy and penetration.
What are the limitations?
The study focused on a specific fungal infection (otomycosis) and a particular drug; broader applicability to other conditions or drugs would require further investigation. Long-term in-vivo efficacy and safety studies were not detailed.